Company intelligence / Profile preview

Yangtze Ventures

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Yangtze Ventures was a Hong Kong-based venture capital firm that specialized in early-stage investments in the life sciences, technology, and environmental sectors in China. Founded in 2001 and formerly listed on the London Stock Exchange's AIM market, the firm aimed to bridge the gap between international investors and the emerging Chinese innovation landscape. Its healthcare portfolio focused on areas such as telemedicine and medical technology, leveraging the growth of China's domestic market. The company was delisted in 2010 and its activities were subsequently absorbed into the First Eastern Investment Group.

Industry: Investors

Beyond the preview

Go deeper on Yangtze Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yangtze Ventures.

Explore the full profile